Avishay Levanovsky

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.

Common Sense Ltd. develops non-intrusive diagnostic panty-liners and swabs, containing built-in sensing capabilities. Its products accurately monitor suspected amniotic leak and vaginal health. The firm's technology also resulted in the development of indicators that are more sensitive to the presence of amniotic fluid in vaginal secretions than to urine. Common Sense was founded by Amnon Kritzman in 1999 and is headquartered in Caesarea, Israel.